Aurobindo Pharma’s unit -- Aurobindo Pharma USA Inc is recalling 7,296 containers of hypertension drug Carvedilol tablets in the US market, due to manufacturing issues. The affected lot contains 6.25 mg Carvedilol tablets, which have been produced in India and distributed in the US by Princeton-based Aurobindo Pharma USA Inc. The company is recalling the lot due to failed impurities/degradation specifications.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
